In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – For patients with multiple myeloma who are not eligible for autologous stem-cell transplantation, a four-drug combination regimen is promising. Adding thalidomide to bortezomib-melphalan-prednisone,…
NEW YORK (Reuters Health) – The GLP-1 receptor agonist exenatide used to treat type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) events, compared…
NEW YORK (Reuters Health) – Adding the anti-VEGF monoclonal antibody bevacizumab to state-of-the-art adjuvant chemotherapy for stage II or III colon cancer does not improve disease-free survival, according…
NEW YORK (Reuters Health) – For patients with significant carotid artery stenosis, undergoing carotid artery stenting (CAS) carries a higher risk of death or stroke than does carotid…
Jonathan Sackier, MD, a Visiting Professor of Surgery at the University of Virginia, discusses the steps needed to reduce the incidence of catheter related blood stream infection (CRBSI).…
Jonathan Sackier, MD, a Visiting Professor of Surgery at the University of Virginia, discusses the complicated issue of calculating the cost of catheter related blood stream infections. (CRBSI).…
Jonathan Sackier, MD, a Visiting Professor of Surgery at the University of Virginia, discusses the incidence and costs of catheter related blood stream infections (CRBSI) in hospitals in…
NEW YORK (Reuters Health) – The percentage of cardiac surgery patients given blood transfusions varies widely from center to center, but a conservative use of transfusions is not…
NEW YORK (Reuters Health) – Deep brain stimulation, of either the globus pallidus or subthalamic nuclei, can provide long-lasting improvement in motor symptoms in many patients with Parkinson’s…
NEW YORK (Reuters Health) – Patients with age-related macular degeneration treated with the anti-VEGF monoclonal antibodies bevacizumab and ranibizumab do not have any higher rates of mortality, MI…
